List of Tables
Table 1. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cell and Gene Therapy CDMO Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cell and Gene Therapy CDMO Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cell and Gene Therapy CDMO Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Cell and Gene Therapy CDMO Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Cell and Gene Therapy CDMO Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2024)
Table 11. Global Cell and Gene Therapy CDMO Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Cell and Gene Therapy CDMO Services Companies Headquarters
Table 13. Global Cell and Gene Therapy CDMO Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Cell and Gene Therapy CDMO Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Cell and Gene Therapy CDMO Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Cell and Gene Therapy CDMO Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Cell and Gene Therapy CDMO Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Cell and Gene Therapy CDMO Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Cell and Gene Therapy CDMO Services Growth Accelerators and Market Barriers
Table 25. North America Cell and Gene Therapy CDMO Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Cell and Gene Therapy CDMO Services Growth Accelerators and Market Barriers
Table 27. Europe Cell and Gene Therapy CDMO Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Cell and Gene Therapy CDMO Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Cell and Gene Therapy CDMO Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Cell and Gene Therapy CDMO Services Investment Opportunities and Key Challenges
Table 31. Central and South America Cell and Gene Therapy CDMO Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Cell and Gene Therapy CDMO Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Cell and Gene Therapy CDMO Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Catalent Corporation Information
Table 35. Catalent Description and Major Businesses
Table 36. Catalent Product Features and Attributes
Table 37. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Catalent Revenue Proportion by Product in 2024
Table 39. Catalent Revenue Proportion by Application in 2024
Table 40. Catalent Revenue Proportion by Geographic Area in 2024
Table 41. Catalent Cell and Gene Therapy CDMO Services SWOT Analysis
Table 42. Catalent Recent Developments
Table 43. Lonza Corporation Information
Table 44. Lonza Description and Major Businesses
Table 45. Lonza Product Features and Attributes
Table 46. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Lonza Revenue Proportion by Product in 2024
Table 48. Lonza Revenue Proportion by Application in 2024
Table 49. Lonza Revenue Proportion by Geographic Area in 2024
Table 50. Lonza Cell and Gene Therapy CDMO Services SWOT Analysis
Table 51. Lonza Recent Developments
Table 52. Thermo Fisher Corporation Information
Table 53. Thermo Fisher Description and Major Businesses
Table 54. Thermo Fisher Product Features and Attributes
Table 55. Thermo Fisher Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Thermo Fisher Revenue Proportion by Product in 2024
Table 57. Thermo Fisher Revenue Proportion by Application in 2024
Table 58. Thermo Fisher Revenue Proportion by Geographic Area in 2024
Table 59. Thermo Fisher Cell and Gene Therapy CDMO Services SWOT Analysis
Table 60. Thermo Fisher Recent Developments
Table 61. WuXi AppTec Corporation Information
Table 62. WuXi AppTec Description and Major Businesses
Table 63. WuXi AppTec Product Features and Attributes
Table 64. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. WuXi AppTec Revenue Proportion by Product in 2024
Table 66. WuXi AppTec Revenue Proportion by Application in 2024
Table 67. WuXi AppTec Revenue Proportion by Geographic Area in 2024
Table 68. WuXi AppTec Cell and Gene Therapy CDMO Services SWOT Analysis
Table 69. WuXi AppTec Recent Developments
Table 70. Charles River Corporation Information
Table 71. Charles River Description and Major Businesses
Table 72. Charles River Product Features and Attributes
Table 73. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Charles River Revenue Proportion by Product in 2024
Table 75. Charles River Revenue Proportion by Application in 2024
Table 76. Charles River Revenue Proportion by Geographic Area in 2024
Table 77. Charles River Cell and Gene Therapy CDMO Services SWOT Analysis
Table 78. Charles River Recent Developments
Table 79. OxfordBioMedica Corporation Information
Table 80. OxfordBioMedica Description and Major Businesses
Table 81. OxfordBioMedica Product Features and Attributes
Table 82. OxfordBioMedica Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. OxfordBioMedica Recent Developments
Table 84. BrammerBio Corporation Information
Table 85. BrammerBio Description and Major Businesses
Table 86. BrammerBio Product Features and Attributes
Table 87. BrammerBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. BrammerBio Recent Developments
Table 89. CELLfor CURE Corporation Information
Table 90. CELLfor CURE Description and Major Businesses
Table 91. CELLfor CURE Product Features and Attributes
Table 92. CELLfor CURE Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. CELLfor CURE Recent Developments
Table 94. OBiO Technology Corporation Information
Table 95. OBiO Technology Description and Major Businesses
Table 96. OBiO Technology Product Features and Attributes
Table 97. OBiO Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. OBiO Technology Recent Developments
Table 99. GenScript Corporation Information
Table 100. GenScript Description and Major Businesses
Table 101. GenScript Product Features and Attributes
Table 102. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. GenScript Recent Developments
Table 104. Esco Corporation Information
Table 105. Esco Description and Major Businesses
Table 106. Esco Product Features and Attributes
Table 107. Esco Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Esco Recent Developments
Table 109. Nikon Corporation Information
Table 110. Nikon Description and Major Businesses
Table 111. Nikon Product Features and Attributes
Table 112. Nikon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Nikon Recent Developments
Table 114. FUJIFILM Corporation Information
Table 115. FUJIFILM Description and Major Businesses
Table 116. FUJIFILM Product Features and Attributes
Table 117. FUJIFILM Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. FUJIFILM Recent Developments
Table 119. Pharmaron Corporation Information
Table 120. Pharmaron Description and Major Businesses
Table 121. Pharmaron Product Features and Attributes
Table 122. Pharmaron Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Pharmaron Recent Developments
Table 124. Porton Corporation Information
Table 125. Porton Description and Major Businesses
Table 126. Porton Product Features and Attributes
Table 127. Porton Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Porton Recent Developments
Table 129. Medicilon Corporation Information
Table 130. Medicilon Description and Major Businesses
Table 131. Medicilon Product Features and Attributes
Table 132. Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Medicilon Recent Developments
Table 134. JOINN Laboratories Corporation Information
Table 135. JOINN Laboratories Description and Major Businesses
Table 136. JOINN Laboratories Product Features and Attributes
Table 137. JOINN Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. JOINN Laboratories Recent Developments
Table 139. Sofpromed Corporation Information
Table 140. Sofpromed Description and Major Businesses
Table 141. Sofpromed Product Features and Attributes
Table 142. Sofpromed Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Sofpromed Recent Developments
Table 144. eXmoor Corporation Information
Table 145. eXmoor Description and Major Businesses
Table 146. eXmoor Product Features and Attributes
Table 147. eXmoor Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. eXmoor Recent Developments
Table 149. OmniaBio Corporation Information
Table 150. OmniaBio Description and Major Businesses
Table 151. OmniaBio Product Features and Attributes
Table 152. OmniaBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. OmniaBio Recent Developments
Table 154. RoslinCT Corporation Information
Table 155. RoslinCT Description and Major Businesses
Table 156. RoslinCT Product Features and Attributes
Table 157. RoslinCT Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. RoslinCT Recent Developments
Table 159. BioCentriq Corporation Information
Table 160. BioCentriq Description and Major Businesses
Table 161. BioCentriq Product Features and Attributes
Table 162. BioCentriq Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. BioCentriq Recent Developments
Table 164. PolTREG Corporation Information
Table 165. PolTREG Description and Major Businesses
Table 166. PolTREG Product Features and Attributes
Table 167. PolTREG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. PolTREG Recent Developments
Table 169. Miltenyi Bioindustry Corporation Information
Table 170. Miltenyi Bioindustry Description and Major Businesses
Table 171. Miltenyi Bioindustry Product Features and Attributes
Table 172. Miltenyi Bioindustry Revenue (US$ Million) and Gross Margin (2020-2025)
Table 173. Miltenyi Bioindustry Recent Developments
Table 174. Raw Materials Key Suppliers
Table 175. Distributors List
Table 176. Market Trends and Market Evolution
Table 177. Market Drivers and Opportunities
Table 178. Market Challenges, Risks, and Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell and Gene Therapy CDMO Services Product Picture
Figure 2. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Autologous Cell Therapy Products Product Picture
Figure 4. Allogeneic Cell Therapy Products Product Picture
Figure 5. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. SMBs
Figure 7. Large Companies
Figure 8. Cell and Gene Therapy CDMO Services Report Years Considered
Figure 9. Global Cell and Gene Therapy CDMO Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 11. Global Cell and Gene Therapy CDMO Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Region (2020-2031)
Figure 13. Global Cell and Gene Therapy CDMO Services Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. Autologous Cell Therapy Products Revenue Market Share by Player in 2024
Figure 16. Allogeneic Cell Therapy Products Revenue Market Share by Player in 2024
Figure 17. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Type (2020-2031)
Figure 18. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Application (2020-2031)
Figure 19. North America Cell and Gene Therapy CDMO Services Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players Cell and Gene Therapy CDMO Services Revenue (US$ Million) in 2024
Figure 21. North America Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Application (2020-2031)
Figure 23. US Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 24. Canada Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 26. Europe Cell and Gene Therapy CDMO Services Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players Cell and Gene Therapy CDMO Services Revenue (US$ Million) in 2024
Figure 28. Europe Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 31. France Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 33. Italy Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 34. Russia Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Cell and Gene Therapy CDMO Services Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players Cell and Gene Therapy CDMO Services Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 40. Japan Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 42. Australia Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 43. India Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore Cell and Gene Therapy CDMO Services Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America Cell and Gene Therapy CDMO Services Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players Cell and Gene Therapy CDMO Services Revenue (US$ Million) in 2024
Figure 51. Central and South America Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil Cell and Gene Therapy CDMO Services Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina Cell and Gene Therapy CDMO Services Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa Cell and Gene Therapy CDMO Services Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players Cell and Gene Therapy CDMO Services Revenue (US$ Million) in 2024
Figure 57. South America Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries Cell and Gene Therapy CDMO Services Revenue (2020-2025) & (US$ Million)
Figure 60. Israel Cell and Gene Therapy CDMO Services Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt Cell and Gene Therapy CDMO Services Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa Cell and Gene Therapy CDMO Services Revenue (2020-2025) & (US$ Million)
Figure 63. Cell and Gene Therapy CDMO Services Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
